scholarly article | Q13442814 |
P50 | author | Matthew Zabel | Q57425681 |
P2093 | author name string | Wolff M Kirsch | |
P2860 | cites work | Microglial interactions with synapses are modulated by visual experience | Q27322943 |
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo | Q27860578 | ||
Neuron-Microglia Dialogue and Hippocampal Neurogenesis in the Aged Brain. | Q37941009 | ||
Rational heterodoxy: cholesterol reformation of the amyloid doctrine | Q38024542 | ||
Review: microglia of the aged brain: primed to be activated and resistant to regulation | Q38049597 | ||
Microglia instruct subventricular zone neurogenesis | Q40231614 | ||
Microglial phagocytosis of fibrillar beta-amyloid through a beta1 integrin-dependent mechanism. | Q40496060 | ||
A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation. | Q40657503 | ||
Complement component C1q modulates the phagocytosis of Abeta by microglia | Q41720670 | ||
Complement C3 deficiency leads to accelerated amyloid beta plaque deposition and neurodegeneration and modulation of the microglia/macrophage phenotype in amyloid precursor protein transgenic mice | Q42001466 | ||
Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain | Q42477525 | ||
Differential distribution and activation of microglia in the brain of male C57BL/6J mice | Q42511099 | ||
Plaque complement activation and cognitive loss in Alzheimer's disease | Q43111970 | ||
C1q, the recognition subcomponent of the classical pathway of complement, drives microglial activation. | Q43187968 | ||
Complement C3 and C4 expression in C1q sufficient and deficient mouse models of Alzheimer's disease | Q43249892 | ||
Characterization of ameboid microglia isolated from developing mammalian brain. | Q43766815 | ||
The Microglial Reaction in the Rat Dorsal Hippocampus following Transient Forebrain Ischemia | Q43830901 | ||
Developmental neuronal death in hippocampus requires the microglial CD11b integrin and DAP12 immunoreceptor | Q44207850 | ||
Absence of C1q leads to less neuropathology in transgenic mouse models of Alzheimer's disease. | Q44241464 | ||
Localization and cell association of C1q in Alzheimer's disease brain | Q44252091 | ||
Neuronal localization of C1q in preclinical Alzheimer's disease | Q44748605 | ||
Microglial phagocytosis induced by fibrillar beta-amyloid and IgGs are differentially regulated by proinflammatory cytokines. | Q46691360 | ||
Microglia promote the death of developing Purkinje cells | Q48016378 | ||
Evidence for synaptic stripping by cortical microglia | Q48351803 | ||
What is immune privilege (not)? | Q48356667 | ||
Potentiation of cortical inhibition by visual deprivation. | Q48438986 | ||
Neurons express proteins of the classical complement pathway in Alzheimer disease. | Q48592170 | ||
Differential immunochemical markers reveal the normal distribution of brain macrophages and microglia in the developing rat brain | Q48616075 | ||
Aggregation state-dependent activation of the classical complement pathway by the amyloid beta peptide. | Q48677054 | ||
Macrophage phagocytosis of myelin in vitro determined by flow cytometry: phagocytosis is mediated by CR3 and induces production of tumor necrosis factor-alpha and nitric oxide. | Q48882573 | ||
Local distribution of microglia in the normal adult human central nervous system differs by up to one order of magnitude. | Q48912035 | ||
Immunoglobulins and complement factors in senile plaques. An immunoperoxidase study. | Q49090173 | ||
Comparison of the effects of unilateral and bilateral eye closure on cortical unit responses in kittens | Q51245933 | ||
Long-term synapse loss induced by focal blockade of postsynaptlc receptors | Q59069374 | ||
Displacement of synaptic terminals from regenerating motoneurons by microglial cells | Q72179911 | ||
Microglial motility in the rat facial nucleus following peripheral axotomy | Q73681218 | ||
Involvement of P2X4 and P2Y12 receptors in ATP-induced microglial chemotaxis | Q79772775 | ||
Structural and functional evidence for microglial expression of C1qR(P), the C1q receptor that enhances phagocytosis | Q28143328 | ||
The classical complement cascade mediates CNS synapse elimination | Q28261273 | ||
Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner | Q28267444 | ||
A new class of membrane-bound chemokine with a CX3C motif | Q28303204 | ||
Control of microglial neurotoxicity by the fractalkine receptor | Q28513748 | ||
Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia | Q28573077 | ||
Fractalkine and CX 3 CR1 regulate hippocampal neurogenesis in adult and aged rats | Q28576101 | ||
Age-dependent resistance to lethal alphavirus encephalitis in mice: analysis of gene expression in the central nervous system and identification of a novel interferon-inducible protective gene, mouse ISG12. | Q28584742 | ||
Synaptic pruning by microglia is necessary for normal brain development | Q29615591 | ||
Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals | Q29619476 | ||
Microglia: a sensor for pathological events in the CNS | Q29620556 | ||
Genetic variation at CR1 increases risk of cerebral amyloid angiopathy | Q30422717 | ||
CX3CR1 deficiency leads to impairment of hippocampal cognitive function and synaptic plasticity | Q30467724 | ||
Enhanced synaptic connectivity and epilepsy in C1q knockout mice | Q30494456 | ||
Microglia shape adult hippocampal neurogenesis through apoptosis-coupled phagocytosis | Q33560182 | ||
C1q enhances microglial clearance of apoptotic neurons and neuronal blebs, and modulates subsequent inflammatory cytokine production | Q33601747 | ||
Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice | Q34076162 | ||
Regulation of tau pathology by the microglial fractalkine receptor | Q34179654 | ||
Microglia mediate the clearance of soluble Abeta through fluid phase macropinocytosis | Q34554154 | ||
Migration and differentiation of neural precursor cells can be directed by microglia | Q34794137 | ||
CX3CR1 in microglia regulates brain amyloid deposition through selective protofibrillar amyloid-β phagocytosis | Q34796584 | ||
CX3CR1 protein signaling modulates microglial activation and protects against plaque-independent cognitive deficits in a mouse model of Alzheimer disease. | Q35213298 | ||
Structural transitions of complement component C3 and its activation products | Q35544520 | ||
C3-dependent mechanism of microglial priming relevant to multiple sclerosis. | Q35734866 | ||
Immune signalling in neural development, synaptic plasticity and disease | Q35811897 | ||
UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis | Q36298197 | ||
A shift in microglial β-amyloid binding in Alzheimer's disease is associated with cerebral amyloid angiopathy. | Q36652260 | ||
Neurotransmitter receptors on microglia. | Q36955350 | ||
Debris clearance by microglia: an essential link between degeneration and regeneration. | Q37092476 | ||
Microglial clearance function in health and disease | Q37222916 | ||
C1q: the perfect complement for a synaptic feast? | Q37283459 | ||
Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease | Q37331433 | ||
Neurotransmission selectively regulates synapse formation in parallel circuits in vivo | Q37353006 | ||
Immune proteins in brain development and synaptic plasticity. | Q37617631 | ||
Synapse formation and maintenance by C1q family proteins: a new class of secreted synapse organizers. | Q37774409 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | microglia | Q1622829 |
P304 | page(s) | 749-756 | |
P577 | publication date | 2013-02-16 | |
P1433 | published in | Ageing Research Reviews | Q762802 |
P1476 | title | From development to dysfunction: microglia and the complement cascade in CNS homeostasis | |
P478 | volume | 12 |
Q44817276 | 'Neuroinflammation' differs categorically from inflammation: transcriptomes of Alzheimer's disease, Parkinson's disease, schizophrenia and inflammatory diseases compared |
Q35825824 | APOE Stabilization by Exercise Prevents Aging Neurovascular Dysfunction and Complement Induction. |
Q40758347 | Anti-NMDA receptor autoantibodies and associated neurobehavioral pathology in mice are dependent on age of first exposure to Toxoplasma gondii |
Q37305891 | Autophagy resolves early retinal inflammation in Igf1-deficient mice |
Q90429677 | Ca2+, Astrocyte Activation and Calcineurin/NFAT Signaling in Age-Related Neurodegenerative Diseases |
Q64997810 | Complement C3 Inhibition Modulates Neurodegeneration in Chronic Traumatic Brain Injury. |
Q47612261 | Complement C3-Deficient Mice Fail to Display Age-Related Hippocampal Decline. |
Q57039780 | Complement C3-Targeted Gene Therapy Restricts Onset and Progression of Neurodegeneration in Chronic Mouse Glaucoma |
Q40246258 | Complement Components Are Expressed by Infiltrating Macrophages/Activated Microglia Early Following Viral Infection |
Q37356880 | Complement component 3 (C3) expression in the hippocampus after excitotoxic injury: role of C/EBPβ. |
Q93170074 | Developmental roles of microglia: A window into mechanisms of disease |
Q38198928 | Estrogen receptor β and Liver X receptor β: biology and therapeutic potential in CNS diseases |
Q36889750 | Fractalkine Attenuates Microglial Cell Activation Induced by Prenatal Stress |
Q30355850 | Function and Dysfunction of Microglia during Brain Development: Consequences for Synapses and Neural Circuits |
Q46972859 | Glia activation and its role in oxidative stress. |
Q38599803 | In Vitro Models for Neurogenesis. |
Q92626425 | Increased expression of schizophrenia-associated gene C4 leads to hypoconnectivity of prefrontal cortex and reduced social interaction |
Q34630522 | Low levels of cerebrospinal fluid complement 3 and factor H predict faster cognitive decline in mild cognitive impairment |
Q59335641 | Metabotropic Glutamate Receptors in Glial Cells: A New Potential Target for Neuroprotection? |
Q55308149 | Mice lacking galectin-3 (Lgals3) function have decreased home cage movement. |
Q38432342 | Microarray analysis of aging-associated immune system alterations in the rostral ventrolateral medulla of F344 rats. |
Q89522833 | Microglia and Parkinson's disease: footprints to pathology |
Q47548797 | Microglia at center stage: a comprehensive review about the versatile and unique residential macrophages of the central nervous system |
Q49804316 | New Insights into the Role of Neuron-Specific Enolase in Neuro-Inflammation, Neurodegeneration, and Neuroprotection. |
Q90184025 | P2Y6 receptor inhibition aggravates ischemic brain injury by reducing microglial phagocytosis |
Q35662879 | RNA-sequencing reveals transcriptional up-regulation of Trem2 in response to bexarotene treatment. |
Q36209324 | Regulation of Macrophage, Dendritic Cell, and Microglial Phenotype and Function by the SOCS Proteins. |
Q33651921 | Serum glycopattern and Maackia amurensis lectin-II binding glycoproteins in autism spectrum disorder |
Q64087538 | Significance of Complement System in Ischemic Stroke: A Comprehensive Review |
Q34545200 | Temporal gene profiling of the 5XFAD transgenic mouse model highlights the importance of microglial activation in Alzheimer's disease |
Q47889401 | The Complement System and Preeclampsia |
Q38210510 | The role of microglial activation in disease progression |
Q26861263 | The role of the immune system in neurodegenerative disorders: Adaptive or maladaptive? |
Q35698522 | Therapeutic potential of mGluR5 targeting in Alzheimer's disease |
Q64099194 | Transcriptional profiling of human microglia reveals grey-white matter heterogeneity and multiple sclerosis-associated changes |
Search more.